Monitoring During Deliberate Hypotensive Anesthesia Clinical Trial
— PPIOfficial title:
The Use of Peripheral Perfusion Index as a Predictor for Patient's Response to Deliberate Hypotension During Functional Endoscopic Sinus Surgery A Prospective Observational Study
NCT number | NCT03007355 |
Other study ID # | N 2015 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 2017 |
Est. completion date | December 2017 |
Verified date | December 2018 |
Source | Cairo University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Hypotensive anesthesia is effective in reducing the intraoperative blood loss. The risk of
hypoperfusion of vital organs continues to be a concern. An adequate monitoring of tissue
perfusion and oxygenation is crucial issue. Peripheral Perfusion Index (PPI) as a noninvasive
new monitoring, can reflect the peripheral perfusion dynamics.
This study is designed to explore the behaviour and trend of PPI during nitroglycerine
induced deliberate hypotensive anesthesia in adult patients undergoing functional endoscopic
sinus surgery (FESS).
Status | Completed |
Enrollment | 50 |
Est. completion date | December 2017 |
Est. primary completion date | October 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Patients, aged from 18-50 years, ASA physical status I and II, undergoing functional endoscopic sinus surgery (FESS) under deliberate hypotensive anesthesia Exclusion Criteria: - Patients with systemic hypertension, cardiovascular disease, cerebrovascular insufficiency, coagulation defects, renal or hepatic insufficiency, and hypersensitivity to the study drugs will be excluded from the study. Patients receiving vasoactive drugs or beta blockers will be also excluded from the study. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | correlation between PPI and T1 | correlation of baseline values of PPI and time required to achieve target mean arterial pressure. | start of nitroglyceirn infusion till target arterial pressure is reached up to 2 hours |